The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity-Reference-Cited by-同舟云学术

The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity

Published:2015-04-08 Issue:11 Volume:35 Page:2474-2482
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Robles-Diaz Mercedes¹,Garcia-Cortes Miren¹,Medina-Caliz Inmaculada¹,Gonzalez-Jimenez Andres¹,Gonzalez-Grande Rocio²,Navarro Jose M.³,Castiella Agustin⁴,Zapata Eva M.⁴,Romero-Gomez Manuel⁵,Blanco Sonia⁶,Soriano German⁷,Hidalgo Ramon⁸,Ortega-Torres Maria⁹,Clavijo Encarnacion⁹,Bermudez-Ruiz Pilar M.⁹,Lucena M. Isabel¹,Andrade Raúl J.¹,

Affiliation:

1. Unidad de Gestión Clínica de Enfermedades Digestivas y Hepatología; Servicio de Farmacología Clínica; Instituto de Investigación Biomédica de Málaga-IBIMA; Hospital Universitario Virgen de la Victoria; Universidad de Málaga; Málaga Spain

2. Unidad de Gestión Clínica de Enfermedades Digestivas; Instituto de Investigación Biomédica de Málaga-IBIMA; Hospital Regional Universitario Carlos Haya; Málaga Spain

3. Unidad de Gestión Clínica de Aparato Digestivo; Hospital Costa del Sol; Marbella Málaga Spain

4. Unidad de Gestión Clínica de Enfermedades Digestivas; Hospital de Mendaro; Guipúzcoa Spain

5. Unidad de Gestión Clínica de Enfermedades Digestivas; Hospital Universitario de Valme; Sevilla Spain

6. Unidad de Gestión Clínica de Enfermedades Digestivas; Hospital de Basurto; Bilbao Spain

7. Unidad de Gestión Clínica de Enfermedades Digestivas; Hospital de Sant Pau; Barcelona Spain

8. Servicio Central de Informática de la Universidad de Málaga; Málaga Spain

9. Unidad de Gestión Clínica Intercentros de Microbiología; Hospitales Universitarios Regional y Virgen de la Victoria; Málaga Spain

Funder

Fondo Europeo de Desarrollo Regional

Agencia Española del Medicamento y Productos Sanitarios

Innovative Medicines Initiative Safer and Faster Evidence-based Translation (IMI-SAFE-T) consortium

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.12834/fullpdf

Reference21 articles.

1. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER) Guidance for Industry Drug-Induced Liver Injury: Premarketing Clinical Evaluation 2009 http://www.fda.gov/downloads/Drugs/.../Guidances/UCM174090.pdf

2. Alanine aminotransferase: a clinical and regulatory tool for detecting liver injury-past, present, and future;Senior;Clin Pharmacol Ther,2012

3. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries;Danan;J Clin Epidemiol,1993

4. Case definition and phenotype standardization in drug-induced liver injury;Aithal;Clin Pharmacol Ther,2011

5. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period;Andrade;Gastroenterology,2005

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferroptosis participated in inhaled polystyrene nanoplastics-induced liver injury and fibrosis;Science of The Total Environment;2024-03

2. Single and Joint Associations of Polycyclic Aromatic Hydrocarbon Exposure with Liver Function during Early Pregnancy;Toxics;2023-10-16

3. Urinary bisphenol A exposure in relation to liver function abnormalities among U.S. adults: results from the National Health and Nutrition Examination Survey, 2003-2016;2023-10-02

4. Independent and combined associations of urinary metals exposure with markers of liver injury: Results from the NHANES 2013–2016;Chemosphere;2023-10

5. Effective Machine Learning Techniques to Detect Fatty Liver Disease;2023 Second International Conference on Electronics and Renewable Systems (ICEARS);2023-03-02